Higher Co-Payments Increase Chance of Early Discontinuation of Breast Cancer Therapy

http://www.sciencedaily.com/releases/2010/12/101211201845.htm

ScienceDaily (Dec. 11, 2010) — A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.

----- (skipping)

..